152 related articles for article (PubMed ID: 2198499)
1. [Thymopentin as adjuvant therapy in the hepatitis B vaccination of non- or hyporesponsive subjects].
Fuliano P; Fontana L; Bigolari M; Bovone U; Orengo G; Astengo F
Minerva Med; 1990 May; 81(5):407-13. PubMed ID: 2198499
[TBL] [Abstract][Full Text] [Related]
2. Thymopentin as adjuvant to hepatitis B vaccination. Results from three double-blind studies.
Grob PJ; Binswanger U; Blumberg A; Gloor HJ; Hany A; Herwig W; Iselin H; Zàruba K; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():107-15. PubMed ID: 3898281
[TBL] [Abstract][Full Text] [Related]
3. Thymopentin as adjuvant therapy to hepatitis B vaccination in formerly non-or hyporesponding hemodialysis patients.
Zàruba K; Grob PJ; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():102-6. PubMed ID: 3898280
[TBL] [Abstract][Full Text] [Related]
4. Thymopentin administration and increase of sero-conversion after B-hepatitis vaccine in diabetic patients.
Pagani S; Cruciani L; Chianelli M; Procaccini E; Pozzilli P
Diabetes Res; 1989 Dec; 12(4):199-201. PubMed ID: 2534655
[TBL] [Abstract][Full Text] [Related]
5. Influence of thymopentin on antibody response, and monocyte and T cell function in hemodialysis patients who fail to respond to hepatitis B vaccination.
Dumann H; Meuer SC; Renschin G; Köhler H
Nephron; 1990; 55(2):136-40. PubMed ID: 2194133
[TBL] [Abstract][Full Text] [Related]
6. Thymopentin in chronic Trichophyton rubrum infection.
Molin L; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():135-8. PubMed ID: 3898286
[TBL] [Abstract][Full Text] [Related]
7. Low dose hepatitis B vaccination in children: benefit of low dose boosters.
Milne A; Moyes CD; Dimitrakakis M
N Z Med J; 1988 Jun; 101(847 Pt 1):370-1. PubMed ID: 2970604
[TBL] [Abstract][Full Text] [Related]
8. [Thymopentin and immune response in patients with cancer].
Petronella P; Ferrone R; Freda F; Valeriani G
Minerva Chir; 1989 Sep; 44(18):2017-20. PubMed ID: 2694011
[TBL] [Abstract][Full Text] [Related]
9. [Thymopentin in a case of autoimmune thrombocytopenia secondary to chronic lymphatic leukemia].
Cantore M; Bucalossi A; Butini P; Carnevali A; Cavion MA; Leoncini L
G Clin Med; 1989; 70(6-7):421, 423, 425. PubMed ID: 2670653
[TBL] [Abstract][Full Text] [Related]
10. [Thymopentin in the treatment of recurrent condylomata acuminata].
Ghetti P; Negosanti M; Andriani GC; Beltrandi E; Maldini M
Minerva Ginecol; 1989 Feb; 41(2):113-6. PubMed ID: 2664577
[TBL] [Abstract][Full Text] [Related]
11. [Thymopentin treatment of ovarian carcinoma: preliminary clinical results].
Garozzo G; Granà G; Lomeo E; La Greca M; Castiglione MG; Caruso M; Curatolo M; Gurgone P
G Ital Oncol; 1988; 8(1):11-3. PubMed ID: 3065223
[No Abstract] [Full Text] [Related]
12. [A case of juvenile rheumatoid arthritis treated with thymopentin].
Tucciarone L; Felici W; Greco L; Mechelli A
Minerva Pediatr; 1989 Feb; 41(2):109-11. PubMed ID: 2661988
[TBL] [Abstract][Full Text] [Related]
13. Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.
Franchimont P; Hauwaert C; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():81-6. PubMed ID: 3898297
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients.
Nevens F; Zuckerman JN; Burroughs AK; Jung MC; Bayas JM; Kallinowski B; Rivas EF; Duvoux C; Neuhaus P; Saliba F; Buti M; Zarski JP; Pons F; Vanlemmens C; Hamtiaux V; Stoffel M
Liver Transpl; 2006 Oct; 12(10):1489-95. PubMed ID: 16964595
[TBL] [Abstract][Full Text] [Related]
15. Thymopentin in the treatment of alopecia areata.
Orecchia G
Dermatologica; 1989; 178(4):231. PubMed ID: 2670621
[No Abstract] [Full Text] [Related]
16. Controlled trial of thymopentin in hemodialysis patients who fail to respond to hepatitis B vaccination.
Donati D; Gastaldi L
Nephron; 1988; 50(2):133-6. PubMed ID: 3065661
[TBL] [Abstract][Full Text] [Related]
17. Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome.
Hamilton G; Zöch G; Rath T; Meissl G
Prog Clin Biol Res; 1989; 308():995-9. PubMed ID: 2528748
[No Abstract] [Full Text] [Related]
18. Influence of thymopentin on postsurgical immune deficiency: a clinical pilot study.
Faist E; Riedel A; Bolla K
Int J Clin Pharmacol Res; 1987; 7(1):83-7. PubMed ID: 3294617
[TBL] [Abstract][Full Text] [Related]
19. [Immunomodulating therapy in chronic polyarthritis with thymopentin. A multicenter placebo-controlled study of 119 patients].
Lemmel EM; Bach GL; Bolten W; Brackertz D; Fahmy Z; Mattern H; Stroehmann I; Wittenborg A
Dtsch Med Wochenschr; 1988 Feb; 113(5):172-6. PubMed ID: 3276492
[TBL] [Abstract][Full Text] [Related]
20. [Brief treatment with thymopentin as adjuvant in vaccination for hepatitis B: controlled study in patients on periodic hemodialysis].
Palestini M; Messina A; Ciaraffo F; De Sanctis GM; Errera G; Corradini SG
Riv Eur Sci Med Farmacol; 1990 Apr; 12(2):135-9. PubMed ID: 2080311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
